NASDAQ:ASPI ASP Isotopes (ASPI) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ASPI Stock Alerts $3.44 +0.06 (+1.78%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$3.34▼$3.5350-Day Range$2.84▼$4.8152-Week Range$0.28▼$4.97Volume719,042 shsAverage Volume764,084 shsMarket Capitalization$168.28 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get ASP Isotopes alerts: Email Address ASP Isotopes MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside59.9% Upside$5.50 Price TargetShort InterestHealthy3.18% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.24Based on 2 Articles This WeekInsider TradingAcquiring Shares$36,651 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.11) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.47 out of 5 starsBasic Materials Sector105th out of 172 stocksMiscellaneous Chemical Products Industry4th out of 5 stocks 3.5 Analyst's Opinion Consensus RatingASP Isotopes has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageASP Isotopes has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.18% of the float of ASP Isotopes has been sold short.Short Interest Ratio / Days to CoverASP Isotopes has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ASP Isotopes has recently increased by 52.13%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldASP Isotopes does not currently pay a dividend.Dividend GrowthASP Isotopes does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASPI. Previous Next 1.0 News and Social Media Coverage News SentimentASP Isotopes has a news sentiment score of -0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.29 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for ASP Isotopes this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ASPI on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added ASP Isotopes to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ASP Isotopes insiders have bought more of their company's stock than they have sold. Specifically, they have bought $36,651.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders26.30% of the stock of ASP Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.80% of the stock of ASP Isotopes is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ASP Isotopes are expected to grow in the coming year, from ($0.11) to ($0.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ASP Isotopes is -7.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ASP Isotopes is -7.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioASP Isotopes has a P/B Ratio of 8.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About ASP Isotopes Stock (NASDAQ:ASPI)ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.Read More ASPI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASPI Stock News HeadlinesApril 20, 2024 | americanbankingnews.comASP Isotopes Inc. to Post FY2024 Earnings of ($0.11) Per Share, HC Wainwright Forecasts (NASDAQ:ASPI)April 19, 2024 | americanbankingnews.comFY2025 Earnings Estimate for ASP Isotopes Inc. (NASDAQ:ASPI) Issued By HC WainwrightApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 18, 2024 | americanbankingnews.comASP Isotopes (NASDAQ:ASPI) Price Target Increased to $5.50 by Analysts at HC WainwrightApril 17, 2024 | markets.businessinsider.comOptimistic Future for ASP Isotopes: Buy Rating with Increased Price Target Amidst Production and Strategic GrowthApril 12, 2024 | investorplace.comASPI Stock Earnings: ASP Isotopes Reported Results for Q4 2023April 11, 2024 | finanznachrichten.deASP Isotopes Inc.: ASP Isotopes Issues Letter to StockholdersApril 11, 2024 | globenewswire.comASP Isotopes Issues Letter to StockholdersApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 9, 2024 | globenewswire.comASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross ProceedsApril 8, 2024 | marketwatch.comASP Isotopes Shares Rise 10% After New Design ContractApril 8, 2024 | globenewswire.comASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear FuelsApril 1, 2024 | msn.comASP Isotopes enters agreement for supply of electronic gasesApril 1, 2024 | finance.yahoo.comASP Isotopes Inc. Enters Into Purchase Agreement With a Leading Semiconductor Company for the Supply of Highly Enriched Electronic GasesFebruary 29, 2024 | msn.comASP Isotopes signs purchase agreement for offering of convertible notes by subsidiaryFebruary 29, 2024 | finance.yahoo.comASP Isotopes Inc. Announces Signing of Purchase Agreement for Offering of Convertible Notes by Quantum Leap EnergyFebruary 22, 2024 | globenewswire.comASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap EnergyFebruary 19, 2024 | msn.comASP Isotopes plans to list Quantum Leap Energy on national exchange after anticipated spin outFebruary 18, 2024 | globenewswire.comASP Isotopes Inc. Announces Proposed Offering of Convertible Notes by Quantum Leap EnergyFebruary 16, 2024 | finance.yahoo.comASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap EnergyFebruary 16, 2024 | globenewswire.comASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap EnergyJanuary 20, 2024 | finance.yahoo.comASP Isotopes Inc.'s (NASDAQ:ASPI) largest shareholders are individual investors with 47% ownership, insiders own 32%January 10, 2024 | finance.yahoo.comASP Isotopes Inc. Provides Corporate UpdateDecember 6, 2023 | markets.businessinsider.comBuy Rating for ASP Isotopes: Innovation and Growth in the Isotope Enrichment MarketDecember 5, 2023 | nasdaq.comHC Wainwright & Co. Initiates Coverage of ASP Isotopes (ASPI) with Buy RecommendationNovember 29, 2023 | morningstar.comASP Isotopes Inc ASPINovember 27, 2023 | finance.yahoo.comASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU)See More Headlines Receive ASPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ASP Isotopes and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/10/2024Today4/27/2024Next Earnings (Estimated)5/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Miscellaneous chemical products Sub-IndustryN/A Current SymbolNASDAQ:ASPI CUSIPN/A CIK1921865 Webwww.aspisotopes.com Phone561-709-3034FaxN/AEmployees76Year FoundedN/APrice Target and Rating Average Stock Price Target$5.50 High Stock Price Target$5.50 Low Stock Price Target$5.50 Potential Upside/Downside+59.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,290,000.00 Net MarginsN/A Pretax Margin-3,764.43% Return on Equity-129.25% Return on Assets-95.89% Debt Debt-to-Equity Ratio0.01 Current Ratio1.85 Quick Ratio1.85 Sales & Book Value Annual Sales$430,000.00 Price / Sales391.36 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / Book8.82Miscellaneous Outstanding Shares48,920,000Free Float36,056,000Market Cap$168.28 million OptionableNot Optionable Beta5.03 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Paul Elliot Mann (Age 47)President, CEO & Executive Chairman Comp: $260kMr. Robert Ainscow (Age 47)CFO & COO Comp: $133.33kDr. Hendrik Strydom B. Sc (Age 63)M. Sc, Ph.D., CTO & Director Comp: $240kKey CompetitorsNorthern Technologies InternationalNASDAQ:NTICGrowGenerationNASDAQ:GRWGOsisko DevelopmentNYSE:ODVPlatinum Group MetalsNYSE:PLGNouveau Monde GraphiteNYSE:NMGView All CompetitorsInsiders & InstitutionsHTLF BankSold 43,000 shares on 4/25/2024Ownership: 0.073%Rathbones Group PLCBought 151,750 shares on 2/13/2024Ownership: 0.311%HTLF BankBought 78,538 shares on 1/31/2024Ownership: 0.161%Robert John Andrew RyanBought 15,596 shares on 1/29/2024Total: $36,650.60 ($2.35/share)Robert John Andrew RyanBought 100 shares on 1/25/2024Total: $254.00 ($2.54/share)View All Insider TransactionsView All Institutional Transactions ASPI Stock Analysis - Frequently Asked Questions Should I buy or sell ASP Isotopes stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ASP Isotopes in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ASPI shares. View ASPI analyst ratings or view top-rated stocks. What is ASP Isotopes' stock price target for 2024? 1 brokers have issued twelve-month price objectives for ASP Isotopes' stock. Their ASPI share price targets range from $5.50 to $5.50. On average, they expect the company's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 59.9% from the stock's current price. View analysts price targets for ASPI or view top-rated stocks among Wall Street analysts. How have ASPI shares performed in 2024? ASP Isotopes' stock was trading at $1.79 at the beginning of 2024. Since then, ASPI stock has increased by 92.2% and is now trading at $3.44. View the best growth stocks for 2024 here. Are investors shorting ASP Isotopes? ASP Isotopes saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 722,000 shares, an increase of 52.1% from the March 31st total of 474,600 shares. Based on an average trading volume of 638,000 shares, the days-to-cover ratio is presently 1.1 days. Currently, 3.2% of the company's stock are sold short. View ASP Isotopes' Short Interest. When is ASP Isotopes' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 17th 2024. View our ASPI earnings forecast. How were ASP Isotopes' earnings last quarter? ASP Isotopes Inc. (NASDAQ:ASPI) announced its earnings results on Wednesday, April, 10th. The company reported ($0.09) EPS for the quarter. The company earned $0.43 million during the quarter. When did ASP Isotopes IPO? ASP Isotopes (ASPI) raised $5 million in an IPO on Thursday, November 10th 2022. The company issued 1,300,000 shares at $4.00 per share. Revere Securities served as the underwriter for the IPO. Who are ASP Isotopes' major shareholders? ASP Isotopes' stock is owned by many different institutional and retail investors. Top institutional investors include HTLF Bank (0.07%). Insiders that own company stock include Duncan Moore, Robert John Andrew Ryan and Todd Wider. View institutional ownership trends. How do I buy shares of ASP Isotopes? Shares of ASPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ASPI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASP Isotopes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
